Form C-U — 20/20 Biolabs, Inc.
0001665160-23-000097 · filed Jan 19, 2023
· via StartEngine Capital, LLC
https://biolabs.io
(possible website — auto-inferred, not verified)
Offering
- Target
- $9,995
- Maximum
- $4,999,995
- Security type
- Other
- Price per security
- —
- Deadline
- —
- Oversubscription
- Accepted
Issuer
- CIK
- 1139685
- Entity
- Corporation
- Jurisdiction
- DE
- Address
- 15810 GAITHER ROAD, SUITE 235
GAITHERSBURG, MD 20877 - Phone
- —
Most recent fiscal year financials
- Total assets
- $10,272,281
- Cash
- —
- Short-term debt
- —
- Long-term debt
- —
- Revenues
- $9,622,332
- COGS
- $4,927,374
- Taxes paid
- —
- Net income
- $2,071,777
Same issuer's Form D filings
-
D · Feb 26, 2025$3M
View the original filing on SEC EDGAR ↗